Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00315_DB00601_nanopub.RASfi85xFjrZv0AFTtzgVnRE5QXBDV3k85eJAyhj_VT9w#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00315_DB00601 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00315_DB00601 label "DDI between Zolmitriptan and Linezolid - The MAO inhibitor, linezolid, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing linezolid are contraindicated. [drugbank_resource:DB00315_DB00601]" assertion.
- drugbank_resource:DB00315_DB00601 identifier "drugbank_resource:DB00315_DB00601" assertion.
- drugbank_resource:DB00315_DB00601 title "DDI between Zolmitriptan and Linezolid - The MAO inhibitor, linezolid, may increase the serum concentration of zolmitriptan by decreasing its metabolism. Concomitant therapy and use of zolmitriptan within two weeks of discontinuing linezolid are contraindicated." assertion.
- drugbank:DB00315 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00601 assertion.
- drugbank:DB00601 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00315_DB00601 assertion.